Objective Individuals with schizophrenia may be at an increased risk for COVID-19 morbidity
due to the disease characteristics. In this study, we aimed to explore the odds of significant …

The current review summarizes case reports attributing autoimmune diseases and phenomena
to various vaccines and suggests potential mechanisms. It has to be emphasized that the …

Background Individuals with schizophrenia have an increased risk of severe COVID-19
outcomes, nonetheless, no previous study has provided a year-long account of this risk, or …

Introduction Psoriasis (PsO) is currently regarded as a systemic inflammatory disease with a
growing burden of post-diagnosis associated comorbidities. To determine the initial burden …

Background There is limited information on the epidemiology of psoriatic arthritis (PsA) in
general and in Middle Eastern populations in particular. The aims of this study were to estimate …

Background Persistence of biologic therapy in psoriatic arthritis (PsA) patients is an important
factor in individualized patient treatment planning and healthcare policy and guideline …

Background The risk of the infection and its complications under this drug class remains to
be determined. Objective To evaluate the risk of COVID-19, COVID-19-associated …

Comorbidities associated with psoriatic arthritis (PsA) include cardiovascular diseases,
diabetes mellitus, and obesity. This study evaluated the association between PsA and common …

Background Individuals with autistic spectrum disorder (ASD) are more susceptible to COVID-19
morbidity and should therefore be prioritized for vaccination. Although individuals with …

In this study we aimed to assess whether individuals with ASD are prone to higher infection
rates, or to severe COVID-19 illness. Individuals with ASD and age- and gender-matched …